Instalab

BMD Z Score (Right Femoral Neck) Test

See whether your hip bones are keeping pace with your age group, before a fracture is the first sign they aren't.

Who benefits from BMD Z Score (Right Femoral Neck) testing

Training Hard in Low-Impact Sports
If you cycle, swim, or row at high volume, your hips may not be getting the loading they need to keep bone density up.
Premenopausal With a Family History
If your mother or grandmother broke a hip, knowing your hip bone trajectory now gives you decades to act on it.
On Long-Term Steroids or Suppressive Thyroid Therapy
These medications quietly accelerate bone loss at the hip; a scan tells you whether yours is being affected.
Lean Frame and Want to Stay Ahead
Low body weight is one of the strongest predictors of low hip bone density, and a baseline scan reveals whether your frame is keeping up.

About BMD Z Score (Right Femoral Neck)

Hip fractures rarely come out of nowhere. They show up at the end of a slow decline in bone strength that often started years earlier. The Z-score at the right femoral neck (the narrow region of bone just below the ball of your hip joint) tells you something a standard bone scan reading alone cannot: how your hip bone density compares to other people your age and sex, not to a young healthy adult.

That distinction matters when you are under 50, premenopausal, or trying to catch a problem early. If your number is well below average for your peers, your skeleton is aging faster than the calendar suggests, and that signal deserves a response while you still have options.

What This Number Actually Measures

The scan itself is a DXA (dual-energy X-ray absorptiometry), a quick, low-radiation imaging test that quantifies how many grams of mineralized bone tissue sit in a specific area of your hip. The femoral neck is one of the most fracture-prone regions of the skeleton, which is why it is measured so carefully. Your raw density value is then converted into a Z-score, where 0 means you are exactly average for your age and sex, negative numbers mean below average, and positive numbers mean above average.

The Z-score is different from the T-score that older adults are more familiar with. The T-score compares you to a young adult at peak bone mass and is used to diagnose osteoporosis after age 50 or after menopause. The Z-score compares you to people your own age and is the preferred reading in children, premenopausal women, and men under 50, where the question is not 'have you lost bone yet?' but 'are you tracking where you should be?'

Fracture Risk

Low femoral neck bone density is the single strongest imaging predictor of hip fracture. Across large cohorts of older adults, each one-unit drop in hip bone density score is associated with roughly a doubling of hip fracture risk. In one large analysis of Asian women, each unit decline in hip bone density T-score doubled the risk of hip fracture, and the same site-specific relationship has been documented in men and women across multiple populations.

Femoral neck density also predicts fractures elsewhere. Genetic profiles that lower bone density correspond to a higher lifetime risk of osteoporotic fractures at the wrist, spine, and hip. The femoral neck is consistently more sensitive to bone loss than the lumbar spine, which means a low reading here often shows up before other sites flag a problem.

Mortality and Other Long-Term Outcomes

Low femoral neck bone density predicts more than just fractures. In a long-running cohort of elderly Japanese women, low femoral neck density independently predicted higher all-cause mortality. A meta-analysis of prospective cohorts found that lower bone density is linked to higher risk of dying from any cause and from cardiovascular disease. Mortality risk falls steeply as femoral neck density rises, plateauing around the osteopenic range and not improving further at very high densities.

A 2023 meta-analysis also found that higher baseline bone density was associated with a reduced risk of developing dementia. The connection is not causal in any direct way; instead, bone density reflects decades of nutrition, hormonal status, physical activity, and chronic inflammation, all of which influence brain aging too.

Conditions That Lower the Number

Many chronic conditions show up as a depressed femoral neck Z-score before they cause obvious problems. Adults with cystic fibrosis show average femoral neck Z-scores around -1.25. Childhood cancer survivors average around -1.0 at the hip. Among adults with axial spondyloarthritis or ankylosing spondylitis, roughly one in three has low femoral neck bone density, often tied to younger age, active inflammation, and poor physical function.

Other populations with frequently low femoral neck density include adults with phenylketonuria, kidney transplant recipients, very-low-birthweight adults, and adults with juvenile-onset systemic lupus erythematosus, where about 18.5% have femoral neck Z-scores below -2.

Athletes and the Cycling Paradox

Being fit does not automatically mean having strong bones. In a study of 93 elite cyclists, low bone density was extremely common at both the spine and hip, tied to low body mass index, prior fractures, lack of bone-loading activity, and inadequate energy intake. Para athletes show a similar pattern. Male endurance athletes with bone stress injuries at trabecular-rich (spongy bone) sites are particularly likely to have low hip density.

If you train hard in low-impact disciplines like cycling or swimming, your hips may not be getting the loading they need to maintain bone, regardless of how aerobically fit you are. This is exactly the kind of mismatch a Z-score can reveal.

Reference Ranges

These thresholds are drawn from the International Society for Clinical Densitometry and published cohort studies. They are most directly applicable to premenopausal women, men under 50, and children; reference databases vary by manufacturer and may use different ethnic mixes, so two scans on different machines can disagree slightly. Compare your results within the same DXA machine over time for the most reliable trend.

Z-ScoreInterpretationWhat It Suggests
Above 0Above average for your age and sexBone density is stronger than typical peers
0 to -1.0Within expected range for ageBone density is in the normal age-matched band
-1.0 to -2.0Low for ageBelow typical peers; worth investigating contributors
Below -2.0Below expected range for ageSignificantly low; warrants workup for secondary causes

In adults over 50 and postmenopausal women, the T-score becomes the more commonly cited number for diagnosing osteopenia (T below -1) and osteoporosis (T at or below -2.5). The Z-score remains useful at any age as a sanity check on whether your bone loss is faster than expected for your years.

Tracking Your Trend

One reading sets a baseline. A trend tells you what is actually happening to your skeleton. Bone density changes slowly, so most people benefit from a baseline scan and a repeat in one to two years, sooner if you are actively trying to change the number through medication or training. Three years is a reasonable retest interval if your baseline is normal and your risk factors are stable, but waiting longer than that misses opportunities to catch decline early.

Two practical points: get your follow-up scans on the same DXA machine if possible, because cross-machine differences can shift a reading by enough to change a diagnosis. And ask your facility to use consistent positioning, since even small rotation of the hip changes the calculated density at the femoral neck.

Decision Pathway for a Low Result

A femoral neck Z-score below -1.0 in a younger adult is worth investigating, not dismissing. The standard next step is a workup for secondary causes of bone loss, which means blood tests for vitamin D, calcium, phosphorus, parathyroid hormone, thyroid function, kidney function, celiac antibodies, and (in men) testosterone. Bone turnover markers like CTX (C-terminal telopeptide) and bone-specific alkaline phosphatase can help clarify whether you are losing bone actively or have stable but low density.

A Z-score below -2.0 is a stronger signal that something is off, and a referral to an endocrinologist or specialist in metabolic bone disease is reasonable. If you have unexplained fractures alongside a low Z-score, the workup becomes more urgent. Lumbar spine bone density and total hip bone density measured during the same DXA scan add context, since some conditions affect one site more than the other.

When Results Can Be Misleading

Unlike a blood test, a DXA scan is not affected by what you ate, when you exercised, or whether you fasted. The main sources of misleading results are technical:

  • Different DXA machines: cross-calibration bias between scanners can shift a femoral neck T-score enough to change an osteoporosis diagnosis. Track yourself on the same machine.
  • Hip osteoarthritis or hardware: arthritis, prior fracture, or surgical hardware in the scan area can falsely elevate or distort the reading.
  • Reference database choice: different manufacturers use different reference populations, so your Z-score may shift slightly when compared across labs even if your actual bone density has not changed.
  • Positioning differences: small changes in how your leg is rotated during the scan can change the calculated femoral neck density. Same machine, same technician when possible.

What Moves This Biomarker

Evidence-backed interventions that affect your BMD Z Score (Right Femoral Neck) level

Increase
High-impact jumping exercise
Structured jumping exercise raises femoral neck bone density faster than almost any non-drug intervention. In a randomized trial of 47 children with short stature, 24 weeks of supervised jumping exercise increased femoral neck bone density Z-score by approximately 1.1 units over baseline. Impact loading triggers bone-forming cells to build new mineralized tissue specifically in the loaded region, which is why low-impact sports like cycling rarely protect the hip.
ExerciseStrong Evidence
Decrease
Long-term oral corticosteroids (glucocorticoids)
Glucocorticoids like prednisone are the most common cause of drug-induced osteoporosis. In juvenile lupus, higher daily corticosteroid doses are associated with lower femoral neck and lumbar spine bone density. These drugs directly suppress bone-forming cells, accelerate bone-resorbing cell activity, and reduce calcium absorption from the gut. If you are on chronic steroids, your femoral neck density is genuinely at risk, not just artifactually shifted.
MedicationStrong Evidence
Decrease
Chronic low energy availability
Persistent under-fueling, common in athletes with disordered eating or simply with high training loads and inadequate intake, suppresses sex hormones and bone formation. Adolescents with anorexia nervosa have significantly lower bone density at the femoral neck than those with atypical anorexia nervosa, and lower body weight tracks with worse bone deficits at all measured sites. Restoring energy balance is the prerequisite for any bone recovery.
LifestyleStrong Evidence
Increase
Transdermal estradiol replacement
In oligo-amenorrhoeic athletes (those with absent or infrequent menstrual periods), 12 months of transdermal estradiol patches improved femoral neck bone density compared to no treatment or to an ethinyl estradiol-containing oral contraceptive pill. This addresses the underlying estrogen deficiency that drives bone loss in athletes with menstrual dysfunction. Restoring estrogen through the skin bypasses the liver effects that blunt the bone benefit of oral contraceptives.
MedicationModerate Evidence
Decrease
TSH-suppressive thyroid hormone therapy
Long-term TSH (thyroid-stimulating hormone) suppression with high-dose levothyroxine, commonly used after thyroid cancer treatment, lowers bone density in postmenopausal women. A meta-analysis found significantly reduced bone density at multiple sites including the hip in postmenopausal women, with smaller or neutral effects in premenopausal women and men. The over-replacement creates a low-grade hyperthyroid state that accelerates bone turnover.
MedicationModerate Evidence
Increase
Anti-TNF biologics (infliximab)
In rheumatoid arthritis, 12 months of infliximab therapy increased femoral neck bone density and Z-score. Chronic inflammation accelerates bone loss, and effective immunosuppression removes that driver. This represents bone protection through disease control rather than direct skeletal effect.
MedicationModerate Evidence
Decrease
Endurance cycling without weight-bearing cross-training
Elite cyclists have a high prevalence of low bone density at the spine and hip, particularly in early-career female riders and advanced-career riders of both sexes. The combination of minimal hip loading, low body mass index, and low energy availability creates an environment in which bone resorption outpaces formation. Cycling alone, without supplemental impact loading or strength training, fails to maintain femoral neck density.
LifestyleModerate Evidence
Increase
Antiresorptive therapy (bisphosphonates, denosumab) during aromatase inhibitor treatment
In postmenopausal women with early breast cancer on aromatase inhibitors (which suppress estrogen and accelerate bone loss), antiresorptive drugs protect bone density and reduce bone turnover. This is the standard guideline-supported intervention when treatment-induced bone loss is expected.
MedicationModerate Evidence
Decrease
Enzyme-inducing anticonvulsants (older generation)
Long-term use of older anticonvulsants like carbamazepine and phenytoin is associated with lower femoral neck bone density, primarily by accelerating vitamin D metabolism in the liver. Newer non-enzyme-inducing anticonvulsants do not show this pattern and may be associated with slightly higher T-scores. If you have been on older antiseizure medications for years, this is a real driver of bone loss, not a measurement artifact.
MedicationModerate Evidence
Increase
Resistance and impact-based exercise program in postmenopausal women
In a randomized trial of 52 postmenopausal women with osteopenia, a structured Kinect-based virtual reality training program over a defined period significantly increased bone mineral density and reduced fracture risk scores. Mechanical loading remains the most reliable non-drug stimulus for bone preservation after menopause.
ExerciseModerate Evidence

Frequently Asked Questions

References

29 studies
  1. Markarian a, Taaffe D, Bettariga F, Luo H, Galvão D, Wilkie J, Peddle-mcintyre C, Newton RUOsteoporosis International2025
  2. Haworth C, Selby P, Webb a, Dodd M, Musson H, Niven R, Economou G, Horrocks a, Freemont a, Mawer E, Adams JThorax1999
  3. Bautista-aguilar L, López-medina C, Ladehesa-pineda L, Abalos-aguilera MC, Ruíz-vilchez D, Garrido-castro JL, Gómez-garcía I, Puche-larrubia M, Salmoral-chamizo a, Collantes-estévez E, Escudero-contreras a, Font-ugalde PJournal of Clinical Medicine2021
  4. Theander L, Willim M, Nilsson J, Karlsson M, ÅKesson K, Jacobsson L, Turesson CRMD Open2020